Brief: Waldencast Announces Sale Of Obagi Medical To Bridgepoint
01/06/2026 12:15
BRIEF-Waldencast Announces Sale Of Obagi Medical To Bridgepoint June 1 (Reuters) - Waldencast PLC WALD.O:
WALDENCAST ANNOUNCES SALE OF OBAGI MEDICAL TO BRIDGEPOINT
WALDENCAST - DEAL VALUED AT UP TO $460 MILLION
WALDENCAST - COMPANY TO REPAY ABOUT $178 MILLION SENIOR SECURED TERM LOAN AT COMPLETION
WALDENCAST - APPOINTS FELIPE DUTRA AS EXECUTIVE CHAIRMAN EFFECTIVE IMMEDIATELY
Source text: ID:nGNX4Wb4nh
Further company coverage: WALD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bridgepoint
See all newsMedia: Bridgepoint weighs $1 billion sale of anti-drone group MyDefence - FT
Spire Healthcare takeover deadline for Toscafund extended to June 25
Brief: T. Rowe Price Associates Holds About 10% Stake In Bridgepoint Group As Of June 4
Holding(s) in Company
Corrected: WRAPUP 2-Partners Group cap fuels fresh concern over private markets